tbuckley/cabot-search huggingface dataset:
Increased Levels of the Heat Shock Protein (hsp) 70 Contribute as a Pro-Survival and Pro-Growth Mechanism in the Transformation of Bone Marrow Progenitor Cells.
Authors: Sandhya Boyapalle, Kathy Rocha, Fei Guo, Purva Bali, Maria Balasis, Warren Fiskus, Sandhya Kumaraswamy, Michael Pranpat, Kapil Bhalla
Journal: Blood (2005)
Targeting Sp1 Transactivation In Waldenstrom's Macroglobulinemia: a Novel Therapeutic Option
Authors: Mariateresa Fulciniti, Samir B. Amin, Varuna Mohan, Guang Yang, Puru Nanjappa, Pierfrancesco Tassone, Rao H Prabhala, Li Cheng, Kenneth C. Anderson, Steven P. Treon, Nikhil C. Munshi
Journal: Blood (2010)
ATPS-22RITANSERIN AND TEMOZOLOMIDE SYNERGIZE AGAINST HUMAN GLIOBLASTOMA IN VITRO AND IN ESTABLISHED TUMORS IN VIVO
Authors: Desiree Floyd, Louisa Boyd, Salome Boroda, Thurl Harris, Benjamin Purow
Journal: Neuro-Oncology (2015)

BACKGROUND: Diacylglycerol Kinase Alpha (DGKa) inhibition with the known inhibitor R59022 results in strong cytotoxicity against glioblastoma cells in vitro.The use of R59022 in vivo against orthotopic xenografts was less successful due to limited solubility, short serum half-life, and possible low penetration of the blood-brain barrier.In addition, the known pro-immune effect of R59022 on DGKa in T-cells is unlikely to occur in immunocompromised mice.We show combined oral treatment with the related compound ritanserin and temozolomide results in markedly prolonged survival in orthotopic GBM xenograft-bearing mice.METHODS: In vitro studies of synergism between temozolomide (25 mM to 150 mM), and ritanserin (2.5 mM to 20 mM), were carried out using alamarBlue assay at 72 hours after treatment.U251 and several glioblastoma stem cell (GSC) lines were used.In GSCs, Perkin Elmer Operetta Digital Phase-Contrast was used to analyze cell numbers.CompuSyn was used generate Chou-Talalay Combination Index (CI) values.200,000 U251 cells were implanted into the right parenchyma of 36 nude female mice.6 days per week (dpw) oral gavage 30 mg/kg temozolomide in H2O and/or 50mg/kg ritanserin in corn oil, or vehicle began 7 days post tumor.A Kaplan-Meier survival curve was generated upon humane endpoints.RESULTS: U251 cells showed synergistic response at 25 mM to 50 mM temozolomide and 2.5 mM ritanserin.For GSC lines, synergy was also observed in cell counts.Median survival for vehicletreated and ritanserin-treated U251-bearing mice was 29 days, and for temozolomide-treated mice was 32 days.At this time, 66% of ritanserinand temozolomide-treated mice have survived 75 days.CONCLUSIONS: Our preliminary results with U251 and GSCs indicate strong synergy between ritanserin and temozolomide in tissue culture, and this was recapitulated in vivo.
Unusual Pulmonary Lesions
Authors: P. W.A. Kunst, G. Sutedja, R. P. Golding, E. Risse, G. Kardos, P. E. Postmus
Journal: Journal of Clinical Oncology (2002)

Article Tools DIAGNOSIS IN ONCOLOGY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2002.20.11.2745 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 12039937 Unusual Pulmonary Lesions Case 1. A Juvenile Bronchopulmonary Fibrosarcoma P. W.A. KunstxP. W.A. KunstSearch for articles by this author , G. SutedjaxG. SutedjaSearch for articles by this author , R. P. GoldingxR. P. GoldingSearch for articles by this author , E. RissexE. RisseSearch for articles by this author , G. KardosxG. KardosSearch for articles by this author , P. E. PostmusxP. E. PostmusSearch for articles by this author Show More Vrije Universiteit Medical Center, Amsterdam, the Netherlands https://doi.org/10.1200/JCO.2002.20.11.2745 First Page Full Text PDF Figures and Tables © 2002 by American Society of Clinical Oncology
Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases
Authors: Milena Vitiello, Alberto Zullo, Luigi Servillo, Francesco Paolo Mancini, Adriana Borriello, Alfonso Giovane, Fulvio Della Ragione, Nunzia D’Onofrio, Maria Luisa Balestrieri
Journal: Ageing Research Reviews (2016)
LEF-1 Transcription Factor Regulates Proliferation and Differentiation of Myeloid Progenitors in Healthy Individuals and in Patients with Severe Congenital Neutropenia (CN).
Authors: Julia Skokowa, Gunnar Cario, Vesna Bucan, Lan Dan, Zheng Wang, Michaela Scherr, Axel Schambach, Cornelia Zeidler, Mathias Eder, Christopher Baum, Martin Stanulla, Karl Welte
Journal: Blood (2005)
Cyclin D2 Dysregulation by Chromosomal Translocations to TCR Loci in T-Cell Acute Lymphoblastic Leukemia (T-ALL).
Authors: Emmanuelle Clappier, Wendy Cuccuini, Jean-Michel Cayuela, Danielle Vecchione, Andre Baruchel, Herve Dombret, Francois Sigaux, Jean Soulier
Journal: Blood (2006)
Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myelodysplastic Syndromes 50 Years or Older. A Retrospective Survey from the EBMT.
Authors: ZiYi Lim, Ronald Brand, Anja van Biezen, Jurgen Finke, Dietger W. Niederwieser, Tapani Ruutu, Rodrigo Martino, Andrea Bacigalupo, Axel Arthur Fauser, Gerhard Ehninger, Noel-Jean Milpied, Donald Bunjes, Nicolaus Kroger, Ghulam Mufti, T.M. de Witte
Journal: Blood (2006)
Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome
Authors: Xiayu Li, Zhangsuo Liu, Li Wang, Rong Wang, Guohua Ding, Wei Shi, Ping Fu, Yani He, Genyang Cheng, Shukun Wu, Bing Chen, Juan Du, Zhiming Ye, Ye Tao, Bengang Huo, Heng Li, Jianghua Chen
Journal: Journal of the American Society of Nephrology (2016)

Glucocorticoid treatment is the first choice therapy for adults with minimal change nephrotic syndrome; however, this therapy associates with many adverse effects. Tacrolimus may be an alternative to conventional glucocorticoid therapy. To investigate this possibility, we conducted a prospective, randomized, controlled trial (WHO International Clinical Trials Registry Platform: ChiCTR-TRC-11001454) in eight renal units across China. We randomized enrolled patients with adult–onset minimal change nephrotic syndrome ( n =119) to receive glucocorticoid therapy or tacrolimus after intravenous methylprednisolone (0.8 mg/kg per day) for 10 days. Patients received a conventional glucocorticoid regimen or tacrolimus monotherapy, starting with 0.05 mg/kg per day (target trough whole–blood level of 4–8 ng/ml) for 16–20 weeks and subsequently tapering over approximately 18 weeks. Remission occurred in 51 of 53 (96.2%; all complete remission) glucocorticoid-treated patients and 55 of 56 (98.3%; 52 complete and three partial remission) tacrolimus-treated patients ( P =0.61 for remission; P =0.68 for complete remission). The groups had similar mean time to remission ( P =0.55). Relapse occurred in 49.0% and 45.5% of the glucocorticoid- and tacrolimus-treated patients, respectively ( P =0.71), with similar time to relapse ( P =0.86). Seven (13.7%) glucocorticoid-treated and four (7.3%) tacrolimus-treated patients suffered frequent relapse ( P =0.28); five glucocorticoid-treated and two tacrolimus-treated patients became drug dependent ( P =0.26). Adverse events occurred more frequently in the glucocorticoid group (128 versus 81 in the tacrolimus group). Seven adverse events in the glucocorticoid group and two adverse events in the tacrolimus group were serious. Consequently, tacrolimus monotherapy after short–term intravenous methylprednisolone is noninferior to conventional glucocorticoid treatment for adult–onset minimal change nephrotic syndrome in this cohort.
Peter Francis King
Authors: Sue King, Richard Lloyd
Journal: BMJ (2016)

Air Vice Marshal Peter Francis King was born to a serving Royal Air Force officer at RAF Cranwell. He gained a Kitchener medical services scholarship in 1941 while at medical school, where he met his future wife, Doreen. The couple married after they qualified. After house jobs they moved to Edinburgh, and in 1947 the RAF posted Peter to Egypt during a cholera epidemic, and then on to Aden and …
Analysis of Prognostic Factors Predictive of Complete Response (CR) to Ibrutinib in Patients with CLL/SLL
Authors: Susan O'Brien, Samantha Jaglowski, John C. Byrd, Rajat Bannerji, Kristie Blum, Christopher P. Fox, Richard R. Furman, Peter Hillmen, Thomas J. Kipps, Marco Montillo, Jeff Sharman, Sam Suzuki, Danelle James, Alvina D. Chu, Steven Coutre
Journal: Blood (2015)
Soda tax brings sharp fall in sugary drink consumption in Californian city
Authors: Michael McCarthy
Journal: BMJ (2016)

Consumption of soda and other sugary beverages in low income neighbourhoods of the US city of Berkeley, California, fell by 21% after the city imposed a “penny per ounce” tax on sugar sweetened beverages, a study has found.1 The observed decline was more than double the predicted 10% reduction, the researchers noted.

The tax, which was passed in November 2014 and implemented in March 2015, applied to sugar sweetened sodas, fruit flavoured drinks, and sweetened water, coffee, and tea …
Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome
Authors: Manon Queudeville, Sarah M. Eckhoff, Karsten Stahnke, Klaus-Michael Debatin, Lueder H. Meyer
Journal: Blood (2008)
Acquired Imatinib Resistance in CML Is Associated with TKD Mutations of the BCR-ABL Fusion Gene and/or Additional Chromosomal Aberrations: Certain TKD Mutations but Not TP53 Mutations Are Associated with Chromosome Instability.
Authors: Susanne Schnittger, Frank Dicker, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood (2008)
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
Authors: Anne Kerbrat, Jean-Christophe Ferré, Pierre Fillatre, Thomas Ronzière, Stéphane Vannier, Béatrice Carsin-Nicol, Sylvain Lavoué, Marc Vérin, Jean-Yves Gauvrit, Yves Le Tulzo, Gilles Edan
Journal: New England Journal of Medicine (2016)

A decrease in fatty acid amide hydrolase (FAAH) activity increases the levels of endogenous analogues of cannabinoids, or endocannabinoids. FAAH inhibitors have shown analgesic and antiinflammatory activity in animal models, and some have been tested in phase 1 and 2 studies. In a phase 1 study, BIA 10-2474, an orally administered reversible FAAH inhibitor, was given to healthy volunteers to assess safety.
Re
Authors: Kamal Kant Sahu, Archana Gautam, Sikander Ailawadhi
Journal: Clinical Nuclear Medicine (2016)

Division of Hematology/Oncology, Department of Internal Medicine, Postgraduate Institute of Medical Education, and Research (PGIMER), Chandigarh, India, [email protected], †Department of Internal Medicine, University College ofMedical Sciences (UCMS), New Delhi, India, ‡Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL Received for publication June 19, 2016; revision accepted September 7, 2016. Conflicts of interest and sources of funding: none declared.
<i>Notes from the Field</i>: Rift Valley Fever Response — Kabale District, Uganda, March 2016
Authors: Annabelle de St. Maurice, Luke Nyakarahuka, Lawrence Purpura, Elizabeth Ervin, Alex Tumusiime, Stephen Balinandi, Jackson Kayondo, Sophia Mulei, Anne Marion Namutebi, Patrick Tusiime, Steven Wiersma, Stuart Nichol, Pierre Rollin, John Klena, Barbara Knust, Trevor Shoemaker
Journal: MMWR Morbidity and Mortality Weekly Report (2016)

On March 9, 2016, a male butcher from Kabale District, Uganda, aged 45 years, reported to the Kabale Regional Referral Hospital with fever, fatigue, and headache associated with black tarry stools and bleeding from the nose. One day later, a student aged 16 years from a different sub-county in Kabale District developed similar symptoms and was admitted to the same hospital. The student also had a history of contact with livestock. Blood specimens collected from both patients were sent for testing for Marburg virus disease, Ebola virus disease, Rift Valley fever (RVF), and Crimean Congo Hemorrhagic fever at the Uganda Virus Research Institute, as part of the viral hemorrhagic fevers surveillance program. The Uganda Virus Research Institute serves as the national viral hemorrhagic fever reference laboratory and hosts the national surveillance program for viral hemorrhagic fevers, in collaboration with the CDC Viral Special Pathogens Branch and the Uganda Ministry of Health.
Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study
Authors: Trisha E. Wong, Meghan Delaney, Terry B. Gernsheimer, Dana C. Matthews, Tom Brogan, Rob Mazor, D. Michael McMullan, Alexander P Reiner, Barbara A. Konkle
Journal: Blood (2012)
Obesity accelerates T cell senescence in murine visceral adipose tissue
Authors: Kohsuke Shirakawa, Xiaoxiang Yan, Ken Shinmura, Jin Endo, Masaharu Kataoka, Yoshinori Katsumata, Tsunehisa Yamamoto, Atsushi Anzai, Sarasa Isobe, Naohiro Yoshida, Hiroshi Itoh, Ichiro Manabe, Miho Sekai, Yoko Hamazaki, Keiichi Fukuda, Nagahiro Minato, Motoaki Sano
Journal: Journal of Clinical Investigation (2016)

Chronic inflammation in visceral adipose tissue (VAT) precipitates the development of cardiometabolic disorders. Although changes in T cell function associated with visceral obesity are thought to affect chronic VAT inflammation, the specific features of these changes remain elusive. Here, we have determined that a high-fat diet (HFD) caused a preferential increase and accumulation of CD44hiCD62LloCD4+ T cells that constitutively express PD-1 and CD153 in a B cell-dependent manner in VAT. These cells possessed characteristics of cellular senescence and showed a strong activation of Spp1 (encoding osteopontin [OPN]) in VAT. Upon T cell receptor stimulation, these T cells also produced large amounts of OPN in a PD-1-resistant manner in vitro. The features of CD153+PD-1+CD44hiCD4+ T cells were highly reminiscent of senescence-associated CD4+ T cells that normally increase with age. Adoptive transfer of CD153+PD-1+CD44hiCD4+ T cells from HFD-fed WT, but not Spp1-deficient, mice into the VAT of lean mice fed a normal diet recapitulated the essential features of VAT inflammation and insulin resistance. Our results demonstrate that a distinct CD153+PD-1+CD44hiCD4+ T cell population that accumulates in the VAT of HFD-fed obese mice causes VAT inflammation by producing large amounts of OPN. This finding suggests a link between visceral adiposity and immune aging.
Coagulopathy in HLA-DR Antigen-Negative Acute Myeloid Leukemia.
Authors: Hideki Uchiumi, Takafumi Matsushima, Arito Yamane, Hiroshi Handa, Hiroyuki Irisawa, Noriko Doki, Tohru Sakura, Yuki Tsumita, Takahiro Jinbo, Norifumi Tsukamoto, Masamitsu Karasawa, Hirokazu Murakami, Shuichi Miyawaki, Yoshihisa Nojima
Journal: Blood (2004)
Unusual Tumors Involving the Head and Neck Region
Authors: Leonid Vilenski, Anil Potti, Syed A. Mehdi
Journal: Journal of Clinical Oncology (2001)

Article Tools DIAGNOSIS IN ONCOLOGY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2001.19.21.4177 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 11689588 Unusual Tumors Involving the Head and Neck Region Case 3. Proptosis due to Metastatic Prostate Cancer Leonid VilenskixLeonid VilenskiSearch for articles by this author , Anil PottixAnil PottiSearch for articles by this author , Syed A. MehdixSyed A. MehdiSearch for articles by this author Show More University of North Dakota School of Medicine and Health Sciences and Veterans Affairs Medical Center, Fargo, ND https://doi.org/10.1200/JCO.2001.19.21.4177 First Page Full Text PDF Figures and Tables © 2001 by American Society of Clinical Oncology
Over-Expression of TRAIL on Donor T Cells Enhances GVT and Suppresses Gvhd Via Elimination of Alloreactive T Cells and Host APC
Authors: Arnab Ghosh, Yildirim Dogan, Amanda M. Holland, Odette M Smith, Lauren F. Young, Mallory L West, Natalie V Singer, Robert R Jenq, Il-Kang Na, Olaf Penack, Alan M Hanash, Martin G. Sauer, Michel Sadelain, Marcel R.M. van den Brink
Journal: Blood (2011)
High Frequency of Engraftment Fever (EF) in Patients with Malignant Lymphoma (ML) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Reduced-Intensity Conditioning Regimen.
Authors: Shigeru Kusumoto, Ryuji Tanosaki, Yasushi Onishi, Daigo Akahane, Kyoko Sugimoto, Yoshiki Terada, Sung-Won Kim, Masahiro Kami, Shin-ichiro Mori, Yuji Heike, Yoichi Takaue, Kensei Tobinai
Journal: Blood (2004)
A Small Molecule PLK1 Inhibitor, MLN0905, Induces An Anti-Tumor Response In Human Models of Diffuse Large B-Cell Lymphoma
Authors: Judy Shi, Kerri Lasky, Vashali Shinde, Matt O Duffey, Bradley Stringer, Mark Qian, Debra Liao, Ray Liu, Youlan Rao, Tricia J Vos, Natalie Roy D'Amore, Marc L Hyer
Journal: Blood (2010)
Lifesaving App for Opioid Users
Authors: Rebecca Voelker
Journal: JAMA (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma in the Pre- and Post-Rituximab Treatment Eras.
Authors: Yasodha Natkunam, Pedro Farinha, Eric D. Hsi, Christine P. Hans, Robert Tibshirani, Laurie H. Sehn, Joseph M. Connors, Shuchun Zhao, Brad Pohlman, John Spinelli, Martin Bast, Arnon Nagler, Ronald Levy, Randy D. Gascoyne, Izidore S. Lossos
Journal: Blood (2007)
Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.
Authors: Sebastian Giebel, Jerzy Wojnar, Malgorzata Krawczyk-Kulis, Iwona Wylezol, Miroslaw Markiewicz, Tomasz Kruzel, Jerzy Holowiecki
Journal: Blood (2004)
Long Term Outcomes of Rituximab, Temozolamide, and High-Dose Methotrexate for Lymphoma Involving the Central Nervous System
Authors: Sarah Jordan Nagle, Nirav N. Shah, Alex Ganetsky, Daniel J. Landsburg, Sunita Dwivedy Nasta, Anthony Mato, Stephen J. Schuster, Donald Edward Tsai, Jakub Svoboda
Journal: Blood (2015)
Endogenous VEGF-C mRNA Expression Increases In Vitro Drug Resistance of Pediatric AML Cells and Is an Independent Prognostic Factor for the Time To Reach Complete Remission in AML.
Authors: Hendrik J.M. de Jonge, Arja ter Elst, H. Marike Boezen, Alida C. Weidenaar, Frank J.G. Scherpen, Jessica C.A. Bouma-ter Steege, Gertjan J.L. Kaspers, Bianca F. Goemans, Ursula Creutzig, Willem A. Kamps, Evelina S.J.M. de Bont
Journal: Blood (2006)
Incidence and Outcomes of Positive Donor Corneoscleral Rim Fungal Cultures after Keratoplasty
Authors: Jesse M. Vislisel, Kenneth M. Goins, Michael D. Wagoner, Gregory A. Schmidt, Benjamin T. Aldrich, Jessica M. Skeie, Cynthia R. Reed, M. Bridget Zimmerman, Mark A. Greiner
Journal: Ophthalmology (2016)
High-Dose Chemoradiotherapy Supported by Marrow Infusions for Advanced Neuroblastoma
Authors: John Graham Pole, James Casper, Gerald Elfenbein, Adrian Gee, Samuel Gross, William Janssen, Penelope Koch, Robert Marcus, Terry Pick, Jonathan Shuster, Wayne Spruce, Paul Thomas, Andrew Yeager
Journal: Journal of Clinical Oncology (1991)

In the report entitled, "High-Dose Chemoradiotherapy Supported by Marrow Infusions for Advanced Neuroblastoma: A Pediatric Oncology Group Study" by Graham Pole et al (J Clin Oncol 9:152–158, 1991), Cook Children's Hospital, Fort Worth, TX was omitted from the list of institutions participating in this study.
Leukemia-Associated Primary Granule Proteins (PGPs) Elastase-2 and Proteinase-3 Are Aberrantly Expressed in Solid Tumors: A Potential Therapeutic Target for PR1-Directed Immunotherapy
Authors: Gheath Alatrash, Luis M Vence, Wendy Woodward, Naoto T Ueno, Jeffrey J Molldrem
Journal: Blood (2008)
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement
Authors: Samir R. Kapadia, Susheel Kodali, Raj Makkar, Roxana Mehran, Ronald M. Lazar, Robert Zivadinov, Michael G. Dwyer, Hasan Jilaihawi, Renu Virmani, Saif Anwaruddin, Vinod H. Thourani, Tamim Nazif, Norman Mangner, Felix Woitek, Amar Krishnaswamy, Stephanie Mick, Tarun Chakravarty, Mamoo Nakamura, James M. McCabe, Lowell Satler, Alan Zajarias, Wilson Y. Szeto, Lars Svensson, Maria C. Alu, Roseann M. White, Carlye Kraemer, Azin Parhizgar, Martin B. Leon, Axel Linke, Raj Makkar, Hasanian Al-Jilaihawi, Samir Kapadia, Amar Krishnaswamy, E. Murat Tuzcu, Stephanie Mick, Susheel Kodali, Tamin Nazif, Vinod Thourani, Vasilis Babaliaros, Chandan Devireddy, Kreton Mavromatis, Ron Waksman, Lowell Satler, Augusto Pichard, Wilson Szeto, Saif Anwaruddin, Prashanth Vallabhajosyula, Jay Giri, Howard Herrmann, Alan Zajarias, John Lasala, Adam Greenbaum, William O’Neill, Marvin Eng, Joshua Rovin, Lang Lin, Douglas Spriggs, Shing-Chiu Wong, Geoffrey Bergman, Arash Salemi, Richard Smalling, Biswajit Kar, Pranav Loyalka, D. Scott Lim, Michael Ragosta, Mark Reisman, James McCabe, Creighton Don, Samin Sharma, Annapoorna Kini, George Dangas, Paul Mahoney, Andrew Morse, Mark Stankewicz, Evelio Rodriguez, Axel Linke, Norman Mangner, Felix Woitek, Christian Frerker, David Cohen
Journal: Journal of the American College of Cardiology (2016)
Activity-Dependent Regulation of Distinct Transport and Cytoskeletal Remodeling Functions of the Dendritic Kinesin KIF21B
Authors: Amy E. Ghiretti, Edda Thies, Mariko K. Tokito, Tianming Lin, E. Michael Ostap, Matthias Kneussel, Erika L.F. Holzbaur
Journal: Neuron (2016)
Circulating Endothelial Cells as Noninvasive Marker of Angiogenesis in Patients with Chronic Lymphocytic Leukemia.
Authors: Joanna Gora-Tybor, Anna Krawczynska, Ewa Lech-Maranda, Anna Szmigielska-Kaplon, Dorota Jesionek-Kupnicka, Jerzy Z. Blonski, Tadeusz Robak
Journal: Blood (2007)
Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation
Authors: Renato Cunha, Marco A. Zago, Sergio Querol, Fernanda Volt, Annalisa Ruggeri, Guillermo Sanz, Fabienne Pouthier, Gesine Kogler, José L. Vicario, Paola Bergamaschi, Riccardo Saccardi, Carmen H. Lamas, Cristina Díaz-de-Heredia, Gerard Michel, Henrique Bittencourt, Marli Tavella, Rodrigo A. Panepucci, Francisco Fernandes, Julia Pavan, Eliane Gluckman, Vanderson Rocha
Journal: Blood (2016)
Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses
Authors: Cafer Adiguzel, Vinod Bansal, Josephine Cunanan, Evangelos Litinas, Debra Hoppensteadt, Jawed Fareed
Journal: Blood (2008)